NCT03417765 2024-10-24
Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas
VectivBio AG
Phase 1/2 Withdrawn
VectivBio AG
Aurora BayCare Medical Center
Spherium Biomed
Providence Health & Services
University College, London
Mashhad University of Medical Sciences